Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in ... late-stage ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Ozempic mimics the GLP-1 hormone the body naturally produces after eating, suppressing appetite and stimulating weight loss.

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The ...

The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...